| 查看: 517 | 回复: 2 | |||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | |||
[求助]
求大侠翻译
|
|||
|
Indeed, ferrocene derivatives have been proposed as antianemics, and one such compound, ferrocerone, was clinically approved in the USSR. To the best of our knowledge, this compoundwas the firstmarketed transition organometal drug. In this context, it is worth mentioning that another ferrocene-containing compound, which is a close derivative of chloroquine, has successfully passed clinical phase II trials as an antimalarial drug candidate The idea of using ruthenium-containing organometallics as anticancer agents was first developed by Tochter et al. [ Last edited by LFJ0319 on 2012-5-28 at 22:49 ] |
回复此楼» 收录本帖的淘帖专辑推荐
 精品翻译集锦 |
» 本帖已获得的红花（最新10朵）
LFJ0319» 猜你喜欢
看来今天不会放榜了？
已经有9人回复
-
让我中一个面上吧！
已经有13人回复
-
人气不行了
已经有7人回复
-
今日不放榜？网传国自然预计 8 月 27 日可查结果
已经有18人回复
-
感觉是下周放榜了
已经有12人回复
-
我面上完蛋了
已经有8人回复
-
只有每年这种时候来逛逛小木虫
已经有25人回复
-
什么时候开奖？
已经有7人回复
-
时间戳又变了
已经有18人回复
-
时间戳又变了8-15
已经有27人回复
8814402
至尊木虫 (职业作家)
- 翻译EPI: 509
- 应助: 18 (小学生)
- 贵宾: 0.381
- 金币: 12921.1
- 散金: 47
- 红花: 16
- 帖子: 4185
- 在线: 357.9小时
- 虫号: 1184404
- 注册: 2011-01-06
- 专业: 药物学其他科学问题
【答案】应助回帖
★ ★ ★ ★ ★ ★
sltmac: 金币+1 2012-05-31 08:51:15
sltmac: 金币+5, 翻译EPI+1 2012-06-20 09:28:49
sltmac: 金币+1 2012-05-31 08:51:15
sltmac: 金币+5, 翻译EPI+1 2012-06-20 09:28:49
| Indeed, ferrocene derivatives have been proposed as antianemics, and one such compound, ferrocerone, was clinically approved in the USSR. 确实，二茂铁衍生物已被推荐为抗贫血药，其中一个化合物已在USSR获得临床许可。To the best of our knowledge, this compoundwas the firstmarketed transition organometal drug. 就我们所知，此化合物是第一个市场化的有机金属药物。In this context, it is worth mentioning that another ferrocene-containing compound, which is a close derivative of chloroquine, has successfully passed clinical phase II trials as an antimalarial drug candidate在这种背景下，值得一提的是，另一个含二茂铁的化合物，是氯喹的亲缘衍生物，已经成功地通过了抗疟候选药物二期临床。The idea of using ruthenium-containing organometallics as anticancer agents was first developed by Tochter et al.采用含钌有机金属化合物为抗肿瘤药物的思想最早由Tochter等提出。 |
2楼2012-05-29 08:26:01
thank! 3楼2012-05-29 10:25:57
40